BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14558599)

  • 21. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
    deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
    Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy.
    Aguilera D; Castellino RC; Janss A; Schniederjan M; McNall R; MacDonald T; Mazewski C
    Childs Nerv Syst; 2018 Feb; 34(2):329-334. PubMed ID: 28965234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies.
    Jakacki RI; Jamison C; Heifetz SA; Caldemeyer K; Hanna M; Sender L
    Med Pediatr Oncol; 1997 Dec; 29(6):553-9. PubMed ID: 9324343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Glantz MJ
    Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
    Arellano-Rodrigo E; López-Guillermo A; Bessell EM; Nomdedeu B; Montserrat E; Graus F
    Eur J Haematol; 2003 Apr; 70(4):219-24. PubMed ID: 12656744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS-related central nervous system lymphomas.
    Chamberlain MC; Kormanik PA
    J Neurooncol; 1999 Jul; 43(3):269-76. PubMed ID: 10563433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
    Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
    Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: a phase II study from the Société Française d'Oncologie Pédiatrique.
    Méresse V; Vassal G; Michon J; De Cervens C; Courbon B; Rubie H; Perel Y; Landman J; Chastagnier P; De Valck C
    J Clin Oncol; 1993 Apr; 11(4):630-7. PubMed ID: 8478658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.
    Newton HB; Slivka MA; Volpi C; Bourekas EC; Christoforidis GA; Baujan MA; Slone W; Chakeres DW
    J Neurooncol; 2003 Jan; 61(1):35-44. PubMed ID: 12587794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of high-dose cyclophosphamide plus high-dose etoposide in malignant brain tumors of children followed by autologous bone marrow rescue].
    Hanada R; Inaba T; Yaginuma A; Hayashi Y; Yamamoto K; Nishimoto H; Tsukiyama T
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):263-8. PubMed ID: 2645835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
    Heyn R; Khan F; Ensign LG; Donaldson SS; Ruymann F; Smith MA; Vietti T; Maurer HM
    Med Pediatr Oncol; 1994; 23(2):99-106. PubMed ID: 8202048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
    Gururangan S; Petros WP; Poussaint TY; Hancock ML; Phillips PC; Friedman HS; Bomgaars L; Blaney SM; Kun LE; Boyett JM
    Clin Cancer Res; 2006 Mar; 12(5):1540-6. PubMed ID: 16533779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
    Holdsworth MT; Raisch DW; Duncan MH; Chavez CM; Leasure MM
    Ann Pharmacother; 1995 Jan; 29(1):16-21. PubMed ID: 7711340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
    Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
    J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study.
    Mantadakis E; Herrera L; Leavey PJ; Bash RO; Winick NJ; Kamen BA
    J Clin Oncol; 2000 Jul; 18(13):2576-81. PubMed ID: 10893289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic approaches to the treatment of meningeal malignancy.
    Blaney SM; Balis FM; Poplack DG
    Oncology (Williston Park); 1991 May; 5(5):107-16; discussion 123, 127. PubMed ID: 1831994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.